SAN FRANCISCO & NEW YORK / Apr 19, 2023 / Business Wire / Today, Ciox Health®, a Datavant company, and Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built around a full stack technology platform, announced that they have renewed and expanded their digital services agreement.
Under the expanded agreement, Oscar will have access to the Datavant Switchboard via Ciox to securely request, retrieve, and digitally deliver clinical data. Through this digital capability, medical record access is improved and turnaround time is reduced, while reducing the burden on providers. The arrangement is expected to deliver a total spend reduction of 25% over the term of the agreement for Oscar under the new contract.
"Ciox's offering, both from a product and financial perspective, is strategically aligned with our broader company objectives," said Scott Blackley, Chief Transformation Officer of Oscar. "After having been a trusted partner for nearly seven years, they continue to help drive meaningful cost savings through scale, while being best positioned to support our consumer-centric, tech-focused business."
“We are thrilled to power the aspirations of the innovative team at Oscar, a long-standing client,” said Bill Horn, Executive Vice President of Payer Growth at Ciox. “By leveraging Datavant Switchboard, Oscar stands out as a leader in digital healthcare data exchange, and this extended relationship will quickly benefit both their members and bottom line.”
About Ciox
Ciox Health, a Datavant company, provides leading clinical data technology that empowers greater health by unlocking the potential of data in medical records. The company leverages a ubiquitous network of clinical data connections to simply and securely connect healthcare decision makers with the data and hidden insights in patient medical records. Ciox helps customers connect, control and comply in solving last mile challenges in clinical interoperability. Supporting a range of connectivity needs from research to revenue cycle, Ciox’s solutions include clinical data acquisition, release of information, and clinical coding. Learn more about Ciox technology and solutions by visiting www.cioxhealth.com or Twitter and LinkedIn.
About Oscar Health
Oscar Health, Inc. (“Oscar”) is the first health insurance company built around a full stack technology platform and a relentless focus on serving its members. At Oscar, our mission is to make a healthier life accessible and affordable for all. Headquartered in New York City, Oscar has been challenging the health care system's status quo since our founding in 2012. The company’s member-first philosophy and innovative approach to care has earned us the trust of over one million members as of January 31, 2023. We offer Individual & Family, Small Group and Medicare Advantage plans, and +Oscar, our full stack technology platform. Our vision is to refactor health care to make good care cost less. Refactor is a term used in software engineering that means to improve the design, structure, and implementation of the software, while preserving its functionality. At Oscar, we take this definition a step further. We improve our members’ experience by building trust through deep engagement, personalized guidance, and rapid iteration.
Last Trade: | US$20.69 |
Daily Change: | 0.02 0.10 |
Daily Volume: | 10,840,737 |
Market Cap: | US$4.610B |
September 15, 2025 August 06, 2025 July 22, 2025 May 07, 2025 February 04, 2025 |
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREChimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREEnd of content
No more pages to load